| Multifunctional RNA nanoparticles KA Afonin, M Viard, AY Koyfman, AN Martins, WK Kasprzak, M Panigaj, ... Nano letters 14 (10), 5662-5671, 2014 | 225 | 2014 |
| Aptamers as modular components of therapeutic nucleic acid nanotechnology M Panigaj, MB Johnson, W Ke, J McMillan, EA Goncharova, M Chandler, ... Therapeutic RNA Nanotechnology, 825-882, 2021 | 113 | 2021 |
| Functionally-interdependent shape-switching nanoparticles with controllable properties JR Halman, E Satterwhite, B Roark, M Chandler, M Viard, A Ivanina, ... Nucleic acids research 45 (4), 2210-2220, 2017 | 102 | 2017 |
| RNA–DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-κB in human cells W Ke, E Hong, RF Saito, MC Rangel, J Wang, M Viard, M Richardson, ... Nucleic acids research 47 (3), 1350-1361, 2019 | 79 | 2019 |
| Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs) M Chandler, MB Johnson, M Panigaj, KA Afonin Therapeutic RNA Nanotechnology, 1045-1060, 2021 | 54 | 2021 |
| Underestimation of the expression of cellular prion protein on human red blood cells M Panigaj, A Brouckova, H Glierova, E Dvorakova, J Simak, JG Vostal, ... Transfusion 51 (5), 1012-1021, 2011 | 32 | 2011 |
| A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins MP Marino, M Panigaj, W Ou, J Manirarora, CH Wei, J Reiser Gene Therapy 22 (3), 280-285, 2015 | 31 | 2015 |
| Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells M Panigaj, H Glier, M Wildova, K Holada PloS one 6 (9), e24599, 2011 | 28 | 2011 |
| Challenges in optimizing RNA nanostructures for large-scale production and controlled therapeutic properties M Chandler, M Panigaj, LA Rolband, KA Afonin Nanomedicine 15 (13), 1331-1340, 2020 | 27 | 2020 |
| Development of monoclonal antibodies specific for glycated prion protein E Dvorakova, M Prouza, O Janouskova, M Panigaj, K Holada Journal of Toxicology and Environmental Health, Part A 74 (22-24), 1469-1475, 2011 | 22 | 2011 |
| The recognition of and reactions to nucleic acid nanoparticles by human immune cells D Bila, Y Radwan, MA Dobrovolskaia, M Panigaj, KA Afonin Molecules 26 (14), 4231, 2021 | 20 | 2021 |
| Controlled organization of inorganic materials using biological molecules for activating therapeutic functionalities M Chandler, B Minevich, B Roark, M Viard, MB Johnson, MH Rizvi, ... ACS applied materials & interfaces 13 (33), 39030-39041, 2021 | 11 | 2021 |
| Aptamer guided delivery of nucleic acid-based nanoparticles M Panigaj, J Reiser DNA and RNA Nanotechnology 2 (1), 42-52, 2016 | 11 | 2016 |
| 2021: an immunotherapy odyssey and the rise of nucleic acid nanotechnology M Panigaj, MA Dobrovolskaia, KA Afonin Nanomedicine 16 (19), 1635-1640, 2021 | 10 | 2021 |
| Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles M Panigaj, E Skelly, D Beasock, I Marriott, MB Johnson, J Salotti, ... Frontiers in Immunology 14, 1053550, 2023 | 7 | 2023 |
| Reconfigurable nucleic acid materials for cancer therapy M Chandler, W Ke, JR Halman, M Panigaj, KA Afonin Nanooncology: Engineering nanomaterials for cancer therapy and diagnosis …, 2018 | 4 | 2018 |
| Expression of the cellular prion protein affects posttransfusion recovery and survival of red blood cells in mice H Glier, J Simak, M Panigaj, MP Gelderman, JG Vostal, K Holada Transfusion 55 (11), 2590-2596, 2015 | 4 | 2015 |
| Break to Build: Isothermal Assembly of Nucleic Acid Nanoparticles (NANPs) via Enzymatic Degradation D Beasock, A Ha, J Halman, M Panigaj, J Wang, NV Dokholyan, ... Bioconjugate Chemistry 34 (6), 1139-1146, 2023 | 3 | 2023 |
| Changes in lepidopteran assemblages in Temnosmrečinská dolina valley (the High Tatra Mts, Slovakia) over the last 55 years L Panigaj, M Panigaj Biologia 63 (4), 582-587, 2008 | 3 | 2008 |
| Challenges in optimizing RNA nanostructures for large-scale production and controlled therapeutic properties (vol 15, pg 1331, 2020) B Chandler, M Panigaj, LA Rolband, KA Afonin Nanomedicine 15 (19), 1915-1916, 2020 | 2 | 2020 |
